Skip to Main Content

Author Details

Siyuan Ding
Washington University School of Medicine
2009
52
23
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36821582Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses.Proc Natl Acad Sci U S A2023
37693422<i>Cryptosporidium</i> infection of human small intestinal epithelial cells induces type III interferon and impairs infectivity of Rotavirus.bioRxiv2023
36930652CMPK2 is a host restriction factor that inhibits infection of multiple coronaviruses in a cell-intrinsic manner.PLoS Biol2023
34864073Adding Fuel to the Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection.Gastroenterology2022
35652656The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells.J Virol2022
35699371Re-Examining Rotavirus Innate Immune Evasion: Potential Applications of the Reverse Genetics System.mBio2022
35862708The Role of the VP4 Attachment Protein in Rotavirus Host Range Restriction in an <i>In Vivo</i> Suckling Mouse Model.J Virol2022
36482976Calpain-2 mediates SARS-CoV-2 entry and represents a therapeutic target.bioRxiv2022
35967392A recombinant murine-like rotavirus with Nano-Luciferase expression reveals tissue tropism, replication dynamics, and virus transmission.Front Immunol2022
36037478Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.J Virol2022
36259589Constructing Dual-Transport Pathways by Incorporating Beaded Nanofillers in Mixed Matrix Membranes for Efficient CO<sub>2</sub> Separation.ACS Appl Mater Interfaces2022
35098923m6A modifications regulate intestinal immunity and rotavirus infection.Elife2022
35012356Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.mBio2022
34849936Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.Inflamm Bowel Dis2022
34048708SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.Immunity2021
34953914Adding Fuel to The Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection.Gastroenterology2021
34903043Rotavirus NSP1 Contributes to Intestinal Viral Replication, Pathogenesis, and Transmission.mBio2021
34791430Inhibitor of growth protein 3 epigenetically silences endogenous retroviral elements and prevents innate immune activation.Nucleic Acids Res2021
34830015Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease.Int J Mol Sci2021
34373857Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.bioRxiv2021
34331991Perspectives for the optimization and utility of the rotavirus reverse genetics system.Virus Res2021
32511401Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.bioRxiv2020
32051268Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo.J Virol2020
33133062When STING Meets Viruses: Sensing, Trafficking and Response.Front Immunol2020
33239446Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.Proc Natl Acad Sci U S A2020
32714117Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.SSRN2020
32735849Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.Cell Host Microbe2020
32759316An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.J Virol2020
32247021Retinoic Acid and Lymphotoxin Signaling Promote Differentiation of Human Intestinal M Cells.Gastroenterology2020
32404436TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.Sci Immunol2020
30511655Fabrication and application of nanoporous polymer ion-track membranes.Nanotechnology2019
35514472Introducing hydrophilic ultra-thin ZIF-L into mixed matrix membranes for CO<sub>2</sub>/CH<sub>4</sub> separation.RSC Adv2019
31767073Mortalin restricts porcine epidemic diarrhea virus entry by downregulating clathrin-mediated endocytosis.Vet Microbiol2019
31527793Enterovirus pathogenesis requires the host methyltransferase SETD3.Nat Microbiol2019
30770472Profiling of rotavirus 3'UTR-binding proteins reveals the ATP synthase subunit ATP5B as a host factor that supports late-stage virus replication.J Biol Chem2019
29662124STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection.Nat Commun2018
30046112New mitochondrial DNA synthesis enables NLRP3 inflammasome activation.Nature2018
30460894Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells.Elife2018
30277244A coupled effect of dehydration and electrostatic interactions on selective ion transport through charged nanochannels.Nanoscale2018
29422511Ultrafast ion sieving using nanoporous polymeric membranes.Nat Commun2018
28636595Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells.Nature2017
28416666Drebrin restricts rotavirus entry by inhibiting dynamin-mediated endocytosis.Proc Natl Acad Sci U S A2017
28746868DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes.Cell Rep2017
28637924VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans.Sci Transl Med2017
27706223Comparative Proteomics Reveals Strain-Specific β-TrCP Degradation via Rotavirus NSP1 Hijacking a Host Cullin-3-Rbx1 Complex.PLoS Pathog2016
23929627Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.Hepatology2014
25045870Peroxisomal MAVS activates IRF1-mediated IFN-λ production.Nat Immunol2014
25015296TRIM15 is a focal adhesion protein that regulates focal adhesion disassembly.J Cell Sci2014
25142126Cytidine deamination and cccDNA degradation: A new approach for curing HBV?Hepatology2014
24429359Long-distance interferon signaling within the brain blocks virus spread.J Virol2014
  • 1 - 50 of 52

Recommended Authors

Laura Martin-Sancho
The Scripps Research Institute
Career Start Year 2018
Number of shared co-authors 3
Aminu S Jahun
University of Cambridge, Addenbrooke's Hospital Level 5
Career Start Year 2017
Number of shared co-authors 2
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 8
Roosheel S Patel
Icahn School of Medicine at Mount Sinai
Career Start Year 2015
Number of shared co-authors 1
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 1
Andreas S Puschnik
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 8
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 6
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 5
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 7
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 3
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 2
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 1
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 6
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 2
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 3
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 1
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 2
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 5
Benjamin R tenOever
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 4
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 7
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 2
Ian Goodfellow
University of Cambridge
Career Start Year 1996
Number of shared co-authors 4
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 6
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 1
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 2
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 6
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 1
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 6

Collaborators

Harry B Greenberg
Stanford University School of Medicine
Co-authored papers 20
Michael S Diamond
Washington University School of Medicine
Co-authored papers 7
Yaw Shin Ooi
Duke-NUS Medical School
Co-authored papers 4
Rita E Chen
Co-authored papers 4
Jonathan Diep
Amgen Inc.
Co-authored papers 4
Jan E Carette
Stanford University School of Medicine
Co-authored papers 4
Elitza S Theel
Division of Clinical Microbiology, Mayo Clinic
Co-authored papers 3
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Co-authored papers 3
Sachdev S Sidhu
School of Pharmacy, University of Waterloo
Co-authored papers 3
Larissa B Thackray
Washington University School of Medicine
Co-authored papers 2
Marcus R Kelly
Stanford University School of Medicine
Co-authored papers 2
Nancie A Mooney
Stanford University School of Medicine
Co-authored papers 2
Peter K Jackson
Stanford University School of Medicine, Center for Clinical Sciences Research
Co-authored papers 2
Walther Mothes
Co-authored papers 1
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Orly Laufman
University of California San Francisco
Co-authored papers 1
Sayantan Bose
Bose Institute
Co-authored papers 1
Christine E Peters
Stanford University School of Medicine
Co-authored papers 1
Lauren M Popov
University of California berkeley
Co-authored papers 1
Eileen Foy
University of California san francisco
Co-authored papers 1
Ruth H??ttenhain
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Peter Sarnow
Stanford University School of Medicine
Co-authored papers 1
Bernd Schnabl
University of California San Diego
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Kristi J Kobluk
Stanford University School of Medicine
Co-authored papers 1
Zhenyu Zhong
Co-authored papers 1
Erik Verschueren
University of California San Francisco
Co-authored papers 1
Jinbo Yang
School of Medicine and Pharmacy, Ocean University of China
Co-authored papers 1
Noah W Palm
Yale University School of Medicine
Co-authored papers 1
Release 1.2